由于输血需求量的不断增加及血液储备不足等问题,急需一种安全有效的血液替代品。血红蛋白氧载体(HBOCs)是一种具有运载氧气能力的红细胞替代物,它以血红蛋白为原料,通过交联、聚合、偶联等化学修饰或者将其封装在人工合成的膜制备而成。基于血红蛋白氧载体保质期长,可以大量储存,在需要的时候可立即使用,也能减少在输血过程中传播病毒的风险等优点,科学家们已经研究出了许多制备血红蛋白氧载体的方法,其中结合纳米技术、层层自组装和模板技术的合成方法不仅简单易行,而且生物材料承载能力良好。使用诸如碳酸钙或碳酸锰等模板,将模板在温和的条件下溶解,操作简单且不会对材料产生影响。这给血红蛋白氧载体的应用提供了良好的技术保障。
Due to the increasing demand for blood transfusion and insufficient blood reserve, a safe and effective blood substitute is urgently needed.Hemoglobin oxygen carriers (HBOCs) area kind of red blood cell substitutes with the ability to carry oxygen, which are prepared from hemoglobin by chemical modification such as cross-linking, polymerization, coupling or encapsulation in synthetic membranes. Due to hemoglobin oxygen carriers have many advantages, including a long shelf life, stored in large quantities and used immediately when needed, as well as reducing the risk of virus transmission during blood transfusions, scientists have developed many methods for preparing HBOCs. Among these methods, the method that combined of nanotechnology, layered self-assembly, and templating technology are not only simple and feasbile, but also have good bearing capacity of the biomaterial. The common templates such as calcium carbonate or manganese carbonate can bedissoloved under mild conditions, which is easy to operate and will not affect the fabricated product. This provides a good technical guarantee for the application of HBOCs.
Research Progress Based on Hemoglobin Oxygen Carrier
Mengyuan Jiang, Mengjie Su, Liang Tian, Jing Li, Chunmei Yu*
School of Public Health , Nantong University, Nantong Jiangsu
Received: Jul. 25th, 2021; accepted: Aug. 9th, 2021; published: Aug. 25th, 2021
ABSTRACT
Due to the increasing demand for blood transfusion and insufficient blood reserve, a safe and effective blood substitute is urgently needed.Hemoglobin oxygen carriers (HBOCs) area kind of red blood cell substitutes with the ability to carry oxygen, which are prepared from hemoglobin by chemical modification such as cross-linking, polymerization, coupling or encapsulation in synthetic membranes. Due to hemoglobin oxygen carriers have many advantages, including a long shelf life, stored in large quantities and used immediately when needed, as well as reducing the risk of virus transmission during blood transfusions, scientists have developed many methods for preparing HBOCs. Among these methods, the method that combined of nanotechnology, layered self-assembly, and templating technology are not only simple and feasbile, but also have good bearing capacity of the biomaterial. The common templates such as calcium carbonate or manganese carbonate can bedissoloved under mild conditions, which is easy to operate and will not affect the fabricated product. This provides a good technical guarantee for the application of HBOCs.
姜梦媛,苏梦杰,田 亮,李 静,于春梅. 基于血红蛋白氧载体的研究进展Research Progress Based on Hemoglobin Oxygen Carrier[J]. 分析化学进展, 2021, 11(03): 144-152. https://doi.org/10.12677/AAC.2021.113016
参考文献ReferencesWilliamson, L.M. and Devine, D.V. (2013) Challenges in the Management of the Blood Supply. Lancet, 381, 1866-1875. https://doi.org/10.1016/S0140-6736(13)60631-5Greinacher, A., Fendrich, K. and Hoffmann, W. (2010) Demographic Changes: The Impact for Safe Blood Supply. Special Issue: XXXIst International Congress of the ISBT, 5, 239-243.
https://doi.org/10.1111/j.1751-2824.2010.01377.xAggarwal, S. and Sharma, V. (2012) Attitudes and Problems Related to Voluntary Blood Donation in India: A Short Communication. Annals of Tropical Medicine and Public Health, 5, 50-52.Moderypawlowski, C. L., Tian, L.L. and Pan, V. (2013) Synthetic Approaches to RBC Mimicry and Oxygen Carrier Systems. Biomacromolecules, 14, 939-948. https://doi.org/10.1021/bm400074tChang, T.M.S. (2012) From Artificial Red Blood Cells, Oxygen Carriers, and Oxygen Therapeutics to Artificial Cells, Nanomedicine, and Beyond. Artificial Cells, Blood Substitutes, and Biotechnology, 40, 197-199.
https://doi.org/10.3109/10731199.2012.662408Napolitano, L.M. (2009) Hemoglobin-Based Oxygen Carriers: First, Second or Third Generation? Human or Bovine? Where Are We Now. Critical Care Clinics, 25, 279-301. https://doi.org/10.1016/j.ccc.2009.01.003Habler, O., Pape, A. and Meier, J. (2005) Artificial Oxygen Carriers as an Alternative to Red Blood Cell Transfusion. Der Anaesthesist, 54, 741-754. https://doi.org/10.1007/s00101-005-0893-3杨懿铭, 王永彬, 范华骅. 抗氧化酶交联的多聚血红蛋白的制备及其自氧化稳定性研究[J]. 临床输血与检验, 2009, 11(3): 199-203.Elmer, J., Alam, H.B. and Wilcox, S.R. (2012) Hemoglobin-Based Oxygen Carriers for Hemorrhagic Shock. Resuscitation, 83, 285-292. https://doi.org/10.1016/j.resuscitation.2011.09.020万英, 周剑涛. 血红蛋白氧载体研究进展[J]. 中国生化药物杂志, 2004(3): 178-180.Tsai, A.G., Cabrales, P. and Intaglietta, M. (2004) Oxygen-Carrying Blood Substitutes: A Microvascular Perspective. Expert Opinion on Biological Therapy, 4, 1147-1157. https://doi.org/10.1517/14712598.4.7.1147Schechter, A.N. and Gladwin, M.T. (2003) Hemoglobin and the Paracrine and Endocrine Functions of Nitric Oxide. New England Journal of Medicine, 348, 1483-1485. https://doi.org/10.1056/NEJMcibr023045Chang, T.M.S. (1971) Stabilisation of Enzymes by Microencapsulation with a Concentrated Protein Solution or by Microencapsulation Followed by Cross-Linking with Glutaraldehyde. Biochemical and Biophysical Research Communications, 44, 1531-1536. https://doi.org/10.1016/S0006-291X(71)80260-7Li, T., Yu, R. and Zhang, H.H. (2006) A Method for Purification and Viral Inactivation of Human Placenta Hemoglobin. Artificial Cells Blood Substitutes and Immobilization Biotechnology, 34, 175-188.
https://doi.org/10.1080/10731190600580231Freytag, J.W. and Templeton, D. (1997) OptroTM (Recombinant Human Hemoglobin): A Therapeutic for the Delivery of Oxygen and the Restoration of Blood Volume in the Treatment of Acute Blood Loss in Trauma and Surgery, in Red Cell Substitutes; Basic Principles and Clinical Application. Marcel Dekker, 325-334.Nelson, D.J. (1998) Blood and Hem AssistTM (DCLHb): Potentially a Complementary Therapeutic Team, in Blood Substitutes: Principles, Methods, Products and Clinical Trials. Basel, Karger, 39-57.Burhop, K., Gordon, D. and Estep, T. (2004) Review of Hemoglobin-Induced Myocardial Lesions. Artificial Cells, Blood Substitutes, and Immobilization Biotechnology, 32, 353-374.Shie, J.W., Yogeswaran, U. and Chen, S.M. (2009) Haemoglobin Immobilized on Nafion Modified Multi-Walled Carbon Nanotubes for O2, H2O2 and CCl3COOH Sensors. Talanta, 78, 896-902.
https://doi.org/10.1016/j.talanta.2008.12.063Chang, T.M.S. (1997) Blood Substitutes: Principles, Methods, Products and Clinical Trials. Basel, Karger, 62-67.Yu, B., Liu, Z. and Chang, T.M.S. (2009) Polyhemoglobin with Different Percentage of Tetrameric Hemoglobin and Effects on Vasoactivity and Electrocardiogram. Artificial Cells, Blood Substitutes, and Biotechnology, 34, 159-173.
https://doi.org/10.1080/10731190600580223Matheson, B., Kwansa, H.E. and Bucci, E. (2002) Vascular Response to Infusions of a Nonextravasating Hemoglobin Polymer. Journal of Applied Physiology, 93, 1479-1486. https://doi.org/10.1152/japplphysiol.00191.2002Chang, T.M.S. (2003) Future Generations of Red Blood Cell Substitutes. Journal of Internal Medicine, 253, 527-535.
https://doi.org/10.1046/j.1365-2796.2003.01151.xAlayash, A.I. (2004) Oxygen Therapeutics: Can We Tame Haemoglobin. Nature Reviews Drug Discovery, 3, 152-159.
https://doi.org/10.1038/nrd1307D’Agnillo, F. and Chang, T.M.S. (1998) Polyhemoglobin-Superoxide Dismutase-Catalase as a Blood Substitute with Antioxidant Properties. Nature Biotechnology, 16, 667-671. https://doi.org/10.1038/nbt0798-667Powanda, D. and Chang, T.M.S. (2002) Cross-Linked Poly Hb superoxide Dismutase-Catalase Supplies Oxygen without Causing Blood Brain Barrier Disruption or Brain Edema in a Rat Model of Transient Global Brain Ischemia-Reperfusion. Artificial Cells, Blood Substitutes, and Biotechnology, 30, 25-42.
https://doi.org/10.1081/BIO-120002725Chang, T.M.S. (2004) Artificial Cell Bioencapsulation in Macro, Micro, Nano, and Molecular Dimensions: Keynote Lecture. Artificial Cells, Blood Substitutes, and Biotechnology, 32, 1-23. https://doi.org/10.1081/BIO-120028665Abuchowski, A. (2016) PEGylated Bovine Carboxyhemoglobin (Sanguinate): Results of Clinical Safety Testing and Use in Patients. In: Elwell, C.E., Leung, T.S., Harrison, D.K., Eds., Oxygen Transport to Tissue XXXVII. Advances in Experimental Medicine and Biology, Springer, New York. https://doi.org/10.1007/978-1-4939-3023-4_58Buehler, P.W., Mehendale, S. and Wang, H. (2000) Resuscitative Effects of Polynitroxylated Alphaalpha-Cross-Linked Hemoglobin Following Severe Hemorrhage in the Rat. Free Radical Biology and Medicine, 29, 764-774.
https://doi.org/10.1016/S0891-5849(00)00383-XCabrales, P. (2013) Examining and Mitigating Acellular Hemoglobin Vasoactivity. Antioxidants & Redox Signaling, 18, 2329-2341. https://doi.org/10.1089/ars.2012.4922Pearce, L.B. (2006) HBOC-201 (Hb Glutamer-250 (Bovine), Hemopure): Clinical Studies, In: Winslow, R.M., Ed., Blood Substitutes, Academic Press, Cambridge, 437-450. https://doi.org/10.1016/B978-012759760-7/50047-0Yu, B.L., Swi, C. and Ming, T. (2004) In Vitro and in Vivo Effects of Polyhaemoglobin-Tyrosinase on Murine B16F10 melanoma. Melanoma Research, 14, 197-202. https://doi.org/10.1097/01.cmr.0000131013.71638.c0Yu, B.L. and Chang, T.M.S. (2004) Effects of Combined Oral Administration and Intravenous Injection on Maintaining Decreased Systemic Tyrosine Levels in Rats. Artificial Cells, Blood Substitutes, and Biotechnology, 32, 129-148.
https://doi.org/10.1081/BIO-120028673Djordjevich, L. and Miller, I.F. (1980) Synthetic Erythrocytes from Lipid Encapsulated Hemoglobin. Experimental Hematology, 8, 584-592.Phillips, W.T., Klipper, R.W., Awasthi, V.D., et al. (1999) Polyethylene Glycol-Modified Liposome-Encapsulated Hemoglobin: a Long Circulating Red Cell Substitute. Journal of Pharmacology and Experimental Therapeutics, 288, 665-670.Simoni, J. (2005) Endothelial Cell Response to Hemoglobin Based Oxygen Carriers. Is the Attenuation of Pathological Reactions Possible. Keio Journal of Medicine, 52, 30-31.Tsuchida, E., Komatsu, T. and Yanagimoto, T. (2010) Preservation Stability and in Vivo Administration of Albumin-Heme Hybrid Solution as an Entirely Synthetic O2-Carrier. Polymers for Advanced Technologies, 13, 845-850.
https://doi.org/10.1002/pat.240Yu, W.P. and Chang, T.M. (1996) Submicron Polymer Membrane Hemoglobin Nanocapsules as Potential Blood Substitutes: Preparation and Characterization. Artificial Cells, Blood Substitutes, and Biotechnology, 24, 169-183.
https://doi.org/10.3109/10731199609117433Chang, T.M.S., Powanda, D. and Yu, W. P. (2003) Analysis of Polyethylene-Glycol-Polylactide Nano-Dimension Artificial Red Blood Cells in Maintaining Systemic Hemoglobin Levels and Prevention of Methemoglobin Formation. Artificial Cells, Blood Substitutes, and Biotechnology, 31, 231-248. https://doi.org/10.1081/BIO-120023155Xu, G. R., Wang, S. H., Zhao, H. L., Wu, S. B., Xu, J. M., Li, L. and Liu, X.Y. (2015) Layer-by-Layer (LBL) Assembly Technology as Promising Strategy for Tailoring Pressure-Driven Desalination Membranes. Journal of Membrane Science, 493, 428-443. https://doi.org/10.1016/j.memsci.2015.06.038Cuomo, F., Lopez, F. and Ceglie, A. (2014) Templated Globules—Applications and Perspectives. Advances in Colloid and Interface Science, 205, 124-133. https://doi.org/10.1016/j.cis.2013.08.003Xiong, Y., Liu, Z.Z., Georgieva, R., Smuda, K., Steffen, A., Sendeski, M., Voigt, A., Patzak, A. and Bäumler, H. (2013) Nonvasoconstrictive Hemoglobin Particles as Oxygen Carriers. ACS Publications, 7, 7454-7461.
https://doi.org/10.1021/nn402073nWang, Y., Wang, L.L., Yu, W.L., Gao, D.W., You, G.X., Li, P.L., Zhang, S., Zhang, J., Hu, T., Zhao, L. and Zhou, H. (2017) A PEGylated Bovine Hemoglobin as a Potent Hemoglobin-Based Oxygen Carrier. Biotechnology Progress, 33, 252-260. https://doi.org/10.1002/btpr.2380Li, H., Jia, Y. and Feng, X. (2017) Facile Fabrication of Robust Polydopamine Microcapsules for Insulin Delivery. Journal of Colloid and Interface Science, 487, 12-19. https://doi.org/10.1016/j.jcis.2016.10.012Xiong, Y., Steffen, A., Andreas, K., Mueller, S., Sternberg, N., Georgieva, R. and Baeumler, H. (2012) Hemoglobin-Based Oxygen Carrier Microparticles: Synthesis, Properties, and in Vitro and in Vivo Investigations. Biomacromolecules, 13, 3292-3300. https://doi.org/10.1021/bm301085xRydzek, G., Ji, Q., Li, M., Schaaf, P., Hill, J.P., Boulmedais, F. and Ariga, K. (2015) Electrochemical Nanoarchitectonics and Layer-by-Layer Assembly: From Basics to Future. Nano Today, 10, 138-167.
https://doi.org/10.1016/j.nantod.2015.02.008Szarpak, A., Cui, D. and Dubreuil, F. (2010) Designing Hyaluronic Acid-Based Layer-by-Layer Capsules as a Carrier for Intracellular Drug Delivery. Biomacromolecules, 11, 713-720. https://doi.org/10.1021/bm9012937Tong, W., Gao, C. and Möhwald, H. (2006) Single Polyelectrolyte Microcapsules Fabricated by Glutaraldehyde-Mediated Covalent Layer-by-Layer Assembly. Macromolecular Rapid Communications, 27, 2078-2083.
https://doi.org/10.1002/marc.200600533Ma, Y., Dong, W.F. and Hempenius, M.A. (2006) Redox-Controlled Molecular Permeability of Composite-Wall Microcapsules. Nature Materials, 5, 724-729. https://doi.org/10.1038/nmat1716Kurapati, R. and Raichur, A.M. (2013) Near-Infrared Light-Responsive Graphene Oxide Composite Multilayer Capsules: A Novel Route for Remote Controlled Drug Delivery. Chemical Communications, 49, 734-736.
https://doi.org/10.1039/C2CC38417EShe, S.P., Li, Q.Q., Shan, B.W., Tong, W.J. and Gao, C.Y. (2013) Fabrication of Red-Blood-Cell-Like Polyelectrolyte Microcapsules and Their Deformation and Recovery Behavior through a Microcapillary. Advanced Materials, 25, 5814-5818. https://doi.org/10.1002/adma.201302875Duan, L., Yan, X., Wang, A., Jia, Y. and Li, J. (2012) Highly Loaded Hemoglobin Spheres as Promising Artificial Oxygen Carriers. ACS Nano, 6, 6897-6904. https://doi.org/10.1021/nn301735uJia, Y., Cui, Y., Fei, J.B., Du, M.C., Dai, L.L., Li, J.B. and Yang, Y. (2012) Construction and Evaluation of Hemoglobin-Based Capsules as Blood Substitutes. Advanced Functional Materials, 22, 1446-1453.
https://doi.org/10.1002/adfm.201102737..